• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMF

IMF BENTHAM LIMITED

3.00% ! $2.58
Currently unlisted.
Add to My Watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IMF
Ann: Update - Dividend/Distribution - IMF 		23/04/18 0 74
23/04/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  74 
IMF
Ann: Dividend Details 		23/04/18 1 295
23/04/18 Last post  Tarvold Comments Created with Sketch.  1  Views Created with Sketch.  295 
IMF
Ann: New Australian Investment - Brambles 		23/04/18 0 94
23/04/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  94 
IMF
Ann: Change in substantial holding 		21/04/18 5 661
21/04/18 Last post  Tarvold Comments Created with Sketch.  5  Views Created with Sketch.  661 
IMF
Ann: Change in substantial holding from PPT 		20/04/18 0 105
20/04/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  105 
IMF
Ann: Investor Presentation - April 2018 		19/04/18 3 496
19/04/18 Last post  Quingees Comments Created with Sketch.  3  Views Created with Sketch.  496 
IMF
Ann: Becoming a substantial holder 		12/04/18 1 340
12/04/18 Last post  Tarvold Comments Created with Sketch.  1  Views Created with Sketch.  340 
IMF
Ann: Interest Payment - IMFHA 		09/04/18 0 96
09/04/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  96 

See All Discussions arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Top Stories

AFT Pharmaceutical's multi-billion R&D opportunity

Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
1414 Degrees: Inside the SiNTL battery pivot to drones, defence HotCopper speaks to 1414 Degrees advisor John Keith King, who is arguing that AI infrastructure and defence are converging.
Flexiroam partners with Etihad Airways to accelerate enterprise growth HotCopper is joined by FlexiRoam founder and CEO Jefrey Ong to discuss a new two-year bargain with the UAE national airline, Etihad Airways.
Nejo approvals the trigger for Askari Metals as maiden Ethiopian campaign looms Askari Metals has spent months laying the groundwork in Ethiopia. Now, the explorer is approaching a new story about the drill core.
Kaoko Metals begins Chalkos drilling HotCopper speaks to Kaoko Metals MD Gerard O’Donovan to discuss the major new phase of exploration at Chalkos in Namibia.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.